Take part in the CANNAVID survey on the impact of COVID-19 on cannabis users
Bus 31/32 and Plus Belle La Nuit (PBLN), in collaboration with INSERM, launch the CANNAVID study on the impact of COVID-19 on the uses, practices and health of regular cannabis users in France.
The main objective of this research is to assess the impact of confinement due to the current coronavirus pandemic on cannabis consumption and consumer health. The questionnaire also looks at the impact of confinement on the experience of the situation, on other use of psychoactive substances and on the strategies put in place for consumption or to cope with a possible shortage.
This research is anonymous. Participants must be daily cannabis users (before confinement), of legal age, resident in France and able to understand French. The questionnaire takes between 15 and 20 minutes to complete.
Le Bus 31/32 is a Marseille-based association that reaches out to drug users. It operates as a CSAPA (Centre de soins, d'accompagnement et de prévention en addictologie) and a CAARUD (Centres d'Accueil et d'Accompagnement à la Réduction de risques pour Usagers de Drogues), and has also set up Plus Belle La Nuit, which is strongly committed to reducing the risks associated with drug use at parties.
The questionnaire is available at this address.
-
Business3 weeks ago
Will CBD edibles be banned on May 15 in France? An update on the situation
-
Cannabis in Austria4 weeks ago
Austrian court deals first blow to proposed tobacco monopoly on hemp flowers
-
Cannabis in France3 weeks ago
Medical cannabis: 92% of the French in favor but 0 access
-
Business4 weeks ago
Germany: an experimental cannabis store near Düsseldorf?
-
Cannabis in Spain4 weeks ago
Spannabis Champions Cup 2026: Bilbao results
-
Business3 weeks ago
Bedrocan unveils Bedromed, a new range of standardized cannabinoid-based formulations
-
Cannabis in the U.S.4 weeks ago
DEA confirms that HHC is federally banned
-
Cannabis in Israel4 weeks ago
Israel turns the page on smoked medical cannabis


You must be logged in to post a comment Login